Eric Stefan Selected Research

Adenosine Triphosphate (ATP)

1/2011

Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric Stefan Research Topics

Disease

5	Neoplasms (Cancer) 01/2019 - 01/2011
1	Atherosclerosis 02/2024
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2024
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Alcoholism (Alcohol Abuse) 01/2020
1	Inflammation (Inflammations) 01/2012
1	Prostatic Neoplasms (Prostate Cancer) 10/2011
1	Pain (Aches) 03/2011

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2011
2	Casein Kinase II (Casein Kinase 2)IBA 01/2012 - 01/2011
2	silmitasertibIBA 10/2011 - 01/2011
2	Carboxylic AcidsIBA 10/2011 - 01/2011
1	EnzymesIBA 02/2024
1	Metalloproteases (Metalloproteinases)IBA 02/2024
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	MetallothioneinIBA 01/2020
1	tepoxalinIBA 01/2020
1	Sulfate TransportersIBA 01/2020
1	Disulfiram (Antabuse)FDA Link 01/2020
1	VanadiumIBA 01/2020
1	KI-MS2-008IBA 01/2019
1	MacrolidesIBA 07/2015
1	lyngbyaloside CIBA 07/2015
1	Formaldehyde (Formol)FDA Link 03/2011
1	Adenosine Triphosphate (ATP)IBA 01/2011

Therapy/Procedure

1	Therapeutics 03/2011